Good morning from #KidneyWk! You can still visit our booth and discover the benefits of ISN membership, including: 💥 #ISNWCN lite.spr.ly/60043ym0 💥 #ISNFrontiers lite.spr.ly/60093ymf 💥 Grants 💥 Our journals @Kidney_Int @KIReports 💥 Research opportunities 💥 & more!

ISNkidneycare's tweet image. Good morning from #KidneyWk!
You can still visit our booth and discover the benefits of ISN membership, including: 
💥 #ISNWCN lite.spr.ly/60043ym0
💥 #ISNFrontiers lite.spr.ly/60093ymf
💥 Grants
💥 Our journals @Kidney_Int @KIReports 
💥 Research opportunities
💥 & more!

Presented today at #KidneyWk: 📚 SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Collaborative Meta-Analysis, from @JAMA_current 🔗Free to read online. ja.ma/4qxp1Dh

JAMA_current's tweet image. Presented today at #KidneyWk: 

📚 SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Collaborative Meta-Analysis, from @JAMA_current

🔗Free to read online. ja.ma/4qxp1Dh

From @JAMA_current: Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure. #KidneyWK @ASNKidney ja.ma/4hM3MJM

JAMAInternalMed's tweet image. From @JAMA_current: Among more than 800 000 CKD-PC participants, discordance between cystatin C and creatinine eGFR values was associated with increased risk of death, cardiovascular events, and kidney failure. 

#KidneyWK @ASNKidney 

ja.ma/4hM3MJM

🧵 JAMA, @JAMAInternalMed, and @JAMANetworkOpen conclude #KidneyWk with impactful findings: In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment.

JAMA_current's tweet image. 🧵 JAMA, @JAMAInternalMed, and @JAMANetworkOpen conclude #KidneyWk with impactful findings: 

In stable AKI patients, indication-based dialysis enabled faster liberation from dialysis and reduced health care resource use compared to conventional thrice-weekly treatment.

Is this the REMODEL Trial that Katherine Tuttle announced at #KidneyWk ? sciencedirect.com/science/articl…


We’re delighted to share the simultaneous publication of the NAVIGATE-Kidney RCT, featured in the Late-Breaking Clinical Trials session at #KidneyWk and published in @KIReports. This important study advances understanding and improves outcomes for Latino patients on

ISNkidneycare's tweet image. We’re delighted to share the simultaneous publication of the NAVIGATE-Kidney RCT, featured in the Late-Breaking Clinical Trials session at #KidneyWk and published in @KIReports.

This important study advances understanding and improves outcomes for Latino patients on

Conservative kidney management (CKM), is an active, patient-centered approach to managing advanced kidney failure without dialysis, has a growing base of evidence, and was featured at #KidneyWk 2025. Read more in #ASNKidneyNews: kidney.pub/KN1801-15

asnpublications's tweet image. Conservative kidney management (CKM), is an active, patient-centered approach to managing advanced kidney failure without dialysis, has a growing base of evidence, and was featured at #KidneyWk 2025. Read more in #ASNKidneyNews: kidney.pub/KN1801-15

Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health. 🧵 #KidneyWK @ASNKidney ja.ma/4oniolr

JAMA_current's tweet image. Meta-analysis: #SGLT2 inhibitors slow kidney decline consistently across CKD severity and albuminuria range, supporting their routine use for kidney health. 🧵 

#KidneyWK @ASNKidney 

ja.ma/4oniolr

🎉 Congratulations to AJKD Editor-in-Chief, Harold Feldman, who was presented with the John P. Peters Award at last month's #KidneyWk!

Join us in recognizing the wide-ranging contributions of Harold (Harv) I. Feldman, at #KidneyWk with the presentation of the John P. Peters Award on Friday, November 7. Read more in #ASNKidneyNews: kidney.pub/KN1710-33

asnpublications's tweet image. Join us in recognizing the wide-ranging contributions of Harold (Harv) I. Feldman, at #KidneyWk with the presentation of the John P. Peters Award on Friday, November 7. Read more in #ASNKidneyNews: kidney.pub/KN1710-33


Presented at #KidneyWk: Dialysis Facility Staffing Ratios and Kidney Transplant Access Among Adolescents and Young Adults. 🔗 Free to read online from @JAMA_current. ja.ma/47dtm70

JAMA_current's tweet image. Presented at #KidneyWk: Dialysis Facility Staffing Ratios and Kidney Transplant Access Among Adolescents and Young Adults. 

🔗 Free to read online from @JAMA_current. ja.ma/47dtm70

In a session at #KidneyWk, speakers highlighted how innovations have improved CKD care, and also advanced health equity. Read more in #ASNKidneyNews: kidney.pub/KN1712-17

asnpublications's tweet image. In a session at #KidneyWk, speakers highlighted how innovations have improved CKD care, and also advanced health equity. Read more in #ASNKidneyNews: kidney.pub/KN1712-17

Great #KidneyWk thanks ⁦@ASNKidney⁩, I had a blast and learned lots. #NephForward

kidney_boy's tweet image. Great #KidneyWk thanks ⁦@ASNKidney⁩, I had a blast and learned lots. #NephForward

At #KidneyWk 2025, onconephrology innovations took center stage with many oral presentations showcasing updates, therapies, and mechanisms. Read about the field's progress in #ASNKidneyNews: kidney.pub/KN1801-12

asnpublications's tweet image. At #KidneyWk 2025, onconephrology innovations took center stage with many oral presentations showcasing updates, therapies, and mechanisms. Read about the field's progress in #ASNKidneyNews: kidney.pub/KN1801-12

✅ Thinking about submitting your #KidneyWk research to @JAMA_current, @JAMAInternalMed, @JAMANetworkOpen, or one of our other Network journals? 💻 This video tells you what to expect from the submission and review process: ja.ma/47vshq6

JAMA_current's tweet card. JAMA Network

youtube.com

YouTube

JAMA Network


Did you miss the ASN Presidential Address at #KidneyWk? Read the address in #ASNKidneyNews, featuring a discussion of momentum and challenges in the fight for a cure to kidney diseases: kidney.pub/KN1712-05

asnpublications's tweet image. Did you miss the ASN Presidential Address at #KidneyWk? Read the address in #ASNKidneyNews, featuring a discussion of momentum and challenges in the fight for a cure to kidney diseases: kidney.pub/KN1712-05

At #KidneyWk 2025, Rebecca Schmidt presented multifaceted strategies to expand kidney care to rural areas. Read #ASNKidneyNews coverage of the presentation here: kidney.pub/KN1712-18

asnpublications's tweet image. At #KidneyWk 2025, Rebecca Schmidt presented multifaceted strategies to expand kidney care to rural areas. Read #ASNKidneyNews coverage of the presentation here: kidney.pub/KN1712-18

At #KidneyWk 2025, four people with kidney disease discussed how dietary changes helped keep their conditions in check. Now, they're working on a kidney cookbook. Read more about their experiences in #ASNKidneyNews: kidney.pub/KN1801-23

asnpublications's tweet image. At #KidneyWk 2025, four people with kidney disease discussed how dietary changes helped keep their conditions in check. Now, they're working on a kidney cookbook. Read more about their experiences in #ASNKidneyNews: kidney.pub/KN1801-23

Far more patients with kidney disease are eligible for home-dialysis compared to those who engage in it. A recent panel at #KidneyWk 2025 says education is critical to adopting the technology: kidney.pub/KN1801-03 #ASNKidneyNews

asnpublications's tweet image. Far more patients with kidney disease are eligible for home-dialysis compared to those who engage in it. A recent panel at #KidneyWk 2025 says education is critical to adopting the technology: kidney.pub/KN1801-03 #ASNKidneyNews

Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss clinical research highlights from the @ASNKidney’s #KidneyWk. ➡️ Updated global estimates of chronic kidney disease (#CKD) ➡️ #SGLT2 inhibitors and fish oil for kidney protection ➡️ Treatment approaches for

JAMA_current's tweet image. Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss clinical research highlights from the @ASNKidney’s #KidneyWk.

➡️ Updated global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors and fish oil for kidney protection
➡️ Treatment approaches for

Your research belongs on a global stage. Showcase it to the kidney community shaping the future, sharing findings and gaining recognition. Submit your research abstract or clinical case report by Wednesday, May 13, at 2:00 p.m. EDT for #KidneyWk ➡️asn.kdny.info/Mlf650YIYGH

ASNKidney's tweet image. Your research belongs on a global stage. Showcase it to the kidney community shaping the future, sharing findings and gaining recognition. 

Submit your research abstract or clinical case report by Wednesday, May 13, at 2:00 p.m. EDT for #KidneyWk ➡️asn.kdny.info/Mlf650YIYGH

Traveling to #KidneyWk from outside the US? Start planning now by securing visas and obtaining invitation letters to be part of the world’s premier nephrology meeting. Denver, CO | October 21–25 Learn more: asn.kdny.info/Xqe650YBzKh PS: Registration and housing open on Wednesday,

ASNKidney's tweet image. Traveling to #KidneyWk from outside the US? Start planning now by securing visas and obtaining invitation letters to be part of the world’s premier nephrology meeting.

Denver, CO | October 21–25
Learn more: asn.kdny.info/Xqe650YBzKh

PS: Registration and housing open on Wednesday,

📢 Call for abstracts is now open for #KidneyWk Bring research abstracts or clinical case reports to a global stage. Share discoveries, gain recognition, and be part of the work shaping the future of kidney health. 🗓️ Deadline: Wednesday, May 13, 2:00 p.m. EDT

ASNKidney's tweet image. 📢 Call for abstracts is now open for #KidneyWk

Bring research abstracts or clinical case reports to a global stage. Share discoveries, gain recognition, and be part of the work shaping the future of kidney health.

🗓️ Deadline: Wednesday, May 13, 2:00 p.m. EDT

The patient voice belongs at ASN Kidney Week. Cele’s Champions provides travel support to attend #KidneyWk, plus ASN membership. Bring your perspective forward as an individual living with kidney disease or care partner representing 850 million people worldwide Learn more:

ASNKidney's tweet image. The patient voice belongs at ASN Kidney Week. Cele’s Champions provides travel support to attend #KidneyWk, plus ASN membership.

Bring your perspective forward as an individual living with kidney disease or care partner representing 850 million people worldwide

Learn more:

🐎Saddling up for #KidneyWk in Houston?🤠Interested in the policy side of #kidneycare? Explore this year's lineup of sessions and events related to #kidney health policy here: asn-online.org/policy/webdocs…


Contact us if you are a #nephrologist considering new opportunities and would like to meet with our team during @ASNKidney Week! ow.ly/egbT50WM40W @nephwhisperer @nephrojobs @louiseNBLU #KidneyWk

USRenaLink's tweet image. Contact us if you are a #nephrologist considering new opportunities and would like to meet with our team during @ASNKidney Week! ow.ly/egbT50WM40W @nephwhisperer @nephrojobs @louiseNBLU #KidneyWk

Meet Us at Kidney Week 2025, 6–9 November 2025, Houston, USA mdpi.com/about/announce… #KidneyWk


Contact JASN Editor-in-Chief @rajmehrotra1122 and Deputy Editor @ManjulaKTamura with your late-breaking clinical trial for expedited consideration and peer review. If accepted, your article will publish online simultaneously with #KidneyWk. Learn more: bit.ly/JASNLBCT

asnpublications's tweet image. Contact JASN Editor-in-Chief @rajmehrotra1122 and Deputy Editor @ManjulaKTamura with your late-breaking clinical trial for expedited consideration and peer review. If accepted, your article will publish online simultaneously with #KidneyWk.
 Learn more: bit.ly/JASNLBCT

Build your #KidneyWk schedule with Learning Pathways that match your interests. Explore sessions in Bones, Stones and Mineral Disorders, Transplantation, Onconephrology, and more. Add the Early Program Transplant Candidates & Recipients for care insight. 🔗asn.kdny.info/EwLf50Wzo0w

ASNKidney's tweet image. Build your #KidneyWk schedule with Learning Pathways that match your interests. Explore sessions in Bones, Stones and Mineral Disorders, Transplantation, Onconephrology, and more. Add the Early Program Transplant Candidates & Recipients for care insight.
🔗asn.kdny.info/EwLf50Wzo0w

👏 Your research deserves recognition. The deadline is approaching for Late-Breaking Clinical Trials at #KidneyWk, with opportunities for the Opening Plenary, press sessions, and top journal visibility. Submit by Tuesday, September 9, at 2:00 p.m. EDT. 🔗asn.kdny.info/sf6s50WN6S6

ASNKidney's tweet image. 👏 Your research deserves recognition. The deadline is approaching for Late-Breaking Clinical Trials at #KidneyWk, with opportunities for the Opening Plenary, press sessions, and top journal visibility.  Submit by Tuesday, September 9, at 2:00 p.m. EDT.

🔗asn.kdny.info/sf6s50WN6S6

Home Dialysis Early Program at #KidneyWk 2025 (Nov 5, Houston). Gain practical knowledge to expand access to home dialysis. Check out program ➡️ buff.ly/hq2bluh Register by Sept 10 for discounted fees ➡️ buff.ly/oWmqncC Please also share with colleagues.


We’re excited to share that we will be on the Exhibitor Floor of ASN #KidneyWk this November! Come meet us at booth 1642 to learn more about our efforts to create a PKD-free future.

Education is at the center of #KidneyWk. Join 12,000+ kidney professionals in Houston, TX, for state-of-the-art lectures, symposia, and plenaries that deliver the latest science and insights. Register today and save—early bird rates end September 11. 👉asn.kdny.info/LaVO50WHFnE



Education is at the center of #KidneyWk. Join 12,000+ kidney professionals in Houston, TX, for state-of-the-art lectures, symposia, and plenaries that deliver the latest science and insights. Register today and save—early bird rates end September 11. 👉asn.kdny.info/LaVO50WHFnE


Thrilled to share that our 5 abstracts have been accepted for #KidneyWk 2025 in Houston, TX! Grateful for the incredible mentorship of Dr. @lamanazzal and the support of our team at @NYULH_DeptofMed . Excited to present and connect! #Nephrology #KidneyWeek

karimjaber40's tweet image. Thrilled to share that our 5 abstracts have been accepted for #KidneyWk 2025 in Houston, TX!
Grateful for the incredible mentorship of Dr. @lamanazzal and the support of our team at @NYULH_DeptofMed .
Excited to present and connect! 
#Nephrology #KidneyWeek

Congratulations, Dr. Sharara! 🌟🫘 Well-deserved recognition, and exciting news about your #KidneyWk abstract — here’s to advancing our understanding of podocyte aging and kidney health! 👏


All these #KidneyWk acceptance and ⭐️ posts are getting me so excited for Houston!!! 3 months


Share your late-breaking research with the world at #KidneyWk!🌍 Take the spotlight during the Opening Plenary, connect with thousands of kidney professionals, and gain recognition from top journals. Submit by Tuesday, September 9, at 2 p.m. EDT.🔗asn.kdny.info/xCba50WEG6Q

ASNKidney's tweet image. Share your late-breaking research with the world at #KidneyWk!🌍 Take the spotlight during the Opening Plenary, connect with thousands of kidney professionals, and gain recognition from top journals.  

Submit by Tuesday, September 9, at 2 p.m. EDT.🔗asn.kdny.info/xCba50WEG6Q

✅️ Interventional Nephrology once again present at Kidney Week. 📈Perú 🇵🇪 with the nephrology team from Hospital Dos de Mayo @H2deMayo, present at #KidneyWk @ASNKidney 📌Results of US-guided percutaneous placement of peritoneal dialysis catheters. #KidneyWk #PocusPerucho 🇵🇪

lluncornefro's tweet image. ✅️ Interventional Nephrology once again present at Kidney Week.
📈Perú 🇵🇪 with the nephrology team from Hospital Dos de Mayo @H2deMayo, present at #KidneyWk @ASNKidney
📌Results of US-guided percutaneous placement of peritoneal dialysis catheters.
#KidneyWk #PocusPerucho 🇵🇪

Build your schedule. Own your #KidneyWk. Explore kidney biology, genetics, pediatrics, and pathology. Add an Early Program in Advances in Research Conference 2025 or Genetics in Clinical Nephrology to sharpen your knowledge. Start planning today 👉asn.kdny.info/V3mQ50Wzb0X

ASNKidney's tweet image. Build your schedule. Own your #KidneyWk. Explore kidney biology, genetics, pediatrics, and pathology. Add an Early Program in Advances in Research Conference 2025 or Genetics in Clinical Nephrology to sharpen your knowledge.

Start planning today 👉asn.kdny.info/V3mQ50Wzb0X

Feeling surreal after #KidneyWk and presenting our project! 😊 I’m taking home advice, ideas, and inspiration to keep pushing toward discoveries in renal medicine 🫘 The mission: do one thing every day that gets us closer to a 🌍 without kidney disease. Thank you @ASNKidney 🤍

JanaSharara's tweet image. Feeling surreal after #KidneyWk and presenting our project! 😊

I’m taking home advice, ideas, and inspiration to keep pushing toward discoveries in renal medicine 🫘

The mission: do one thing every day that gets us closer to a 🌍 without kidney disease. Thank you @ASNKidney 🤍
JanaSharara's tweet image. Feeling surreal after #KidneyWk and presenting our project! 😊

I’m taking home advice, ideas, and inspiration to keep pushing toward discoveries in renal medicine 🫘

The mission: do one thing every day that gets us closer to a 🌍 without kidney disease. Thank you @ASNKidney 🤍
JanaSharara's tweet image. Feeling surreal after #KidneyWk and presenting our project! 😊

I’m taking home advice, ideas, and inspiration to keep pushing toward discoveries in renal medicine 🫘

The mission: do one thing every day that gets us closer to a 🌍 without kidney disease. Thank you @ASNKidney 🤍
JanaSharara's tweet image. Feeling surreal after #KidneyWk and presenting our project! 😊

I’m taking home advice, ideas, and inspiration to keep pushing toward discoveries in renal medicine 🫘

The mission: do one thing every day that gets us closer to a 🌍 without kidney disease. Thank you @ASNKidney 🤍

Flying back home from kidney week with a lot of motivation and inspiration.. dreaming and working everyday towards a world where kidney disease is curable 🫘 ❤️thank you @ASNKidney ! #KidneyWk @CleClinicKidney @CCF_IMCHIEFS

JanaSharara's tweet image. Flying back home from kidney week with a lot of motivation and inspiration.. dreaming and working everyday towards a world where kidney disease is curable 🫘 ❤️thank you @ASNKidney ! #KidneyWk @CleClinicKidney @CCF_IMCHIEFS
JanaSharara's tweet image. Flying back home from kidney week with a lot of motivation and inspiration.. dreaming and working everyday towards a world where kidney disease is curable 🫘 ❤️thank you @ASNKidney ! #KidneyWk @CleClinicKidney @CCF_IMCHIEFS

Outstanding session on Hot topics in LupusNephritis. Covered it all, from next-gen treatment targets to complement inhibition. Fantastic lineup moderated by Dr. @SaynaNorouzi and Dr. Mejia-Vilet. #KidneyWk

ZohrehGh7's tweet image. Outstanding session on Hot topics in LupusNephritis. Covered it all, from next-gen treatment targets to complement inhibition. Fantastic lineup moderated by Dr. @SaynaNorouzi and Dr. Mejia-Vilet. #KidneyWk
ZohrehGh7's tweet image. Outstanding session on Hot topics in LupusNephritis. Covered it all, from next-gen treatment targets to complement inhibition. Fantastic lineup moderated by Dr. @SaynaNorouzi and Dr. Mejia-Vilet. #KidneyWk
ZohrehGh7's tweet image. Outstanding session on Hot topics in LupusNephritis. Covered it all, from next-gen treatment targets to complement inhibition. Fantastic lineup moderated by Dr. @SaynaNorouzi and Dr. Mejia-Vilet. #KidneyWk

If we had ⁦@JPetiPeterdi⁩, that would have been the last four chairs of PBKD study section ⁦@NIH⁩ ⁦@NIDDKgov⁩. Great to see Chip Brosius and ⁦@SusanQuaggin#kidneywk 2025 🤞🏽science comeback🤞🏽

samirparikhmd's tweet image. If we had ⁦@JPetiPeterdi⁩, that would have been the last four chairs of PBKD study section ⁦@NIH⁩ ⁦@NIDDKgov⁩. 

Great to see Chip Brosius and ⁦@SusanQuaggin⁩
#kidneywk 2025

🤞🏽science comeback🤞🏽

Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss clinical research highlights from the @ASNKidney’s #KidneyWk. ➡️ Updated global estimates of chronic kidney disease (#CKD) ➡️ #SGLT2 inhibitors and fish oil for kidney protection ➡️ Treatment approaches for

JAMA_current's tweet image. Katherine Tuttle, MD, joins the JAMA Medical News podcast to discuss clinical research highlights from the @ASNKidney’s #KidneyWk.

➡️ Updated global estimates of chronic kidney disease (#CKD)
➡️ #SGLT2 inhibitors and fish oil for kidney protection
➡️ Treatment approaches for

A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy ca. 2025 from @NEJM #Nephpearls #KidneyWk #VisualAbstract by @NephroSeeker @NephJC 👉🏼 pubmed.ncbi.nlm.nih.gov/41196369/

edgarvlermamd's tweet image. A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy ca. 2025 from @NEJM 
#Nephpearls #KidneyWk

#VisualAbstract by @NephroSeeker @NephJC 

👉🏼 pubmed.ncbi.nlm.nih.gov/41196369/

Another reason to love #kidneywk…celebrating innovation and our kidney community’s camaraderie with the home team ⁦@UTSWNephrology

samirparikhmd's tweet image. Another reason to love #kidneywk…celebrating innovation and our kidney community’s camaraderie with the home team ⁦@UTSWNephrology⁩

Legacy of ASN-AHA Donald Seldin Young Investigator Award is in great hands with ⁦@rkramann#kidneywk 2025 Seldin ‘19, ‘23, ‘25 🏆🏆🏆

samirparikhmd's tweet image. Legacy of ASN-AHA Donald Seldin Young Investigator Award is in great hands with ⁦@rkramann⁩ #kidneywk 2025

Seldin ‘19, ‘23, ‘25 🏆🏆🏆

💬 @JAMA_current Editorial: #SGLT2 inhibitor treatment benefits extend to people with CKD and low albuminuria, as well as those with advanced #KidneyDisease, supporting wider use. #KidneyWk @ASNKidney ja.ma/492OrCp

JAMAInternalMed's tweet image. 💬 @JAMA_current Editorial: #SGLT2 inhibitor treatment benefits extend to people with CKD and low albuminuria, as well as those with advanced #KidneyDisease, supporting wider use. 

#KidneyWk @ASNKidney 

ja.ma/492OrCp

1/6 Hilo🧵 Tercer sesión de High-Impact Clinical Trials en el ASN #KidneyWk En síndrome de Alport, Setanaxib (bloqueador de la vía de especies reactivas de oxígeno), comparado a placebo, únicamente ↓15% proteinuria, al menos fue seguro Ensayo clínico

JonathanNefro's tweet image. 1/6
Hilo🧵 

Tercer sesión de High-Impact Clinical Trials en el ASN #KidneyWk 

En síndrome de Alport, Setanaxib (bloqueador de la vía de especies reactivas de oxígeno), comparado a placebo, únicamente ↓15% proteinuria, al menos fue seguro 

Ensayo clínico

At #KidneyWk? ➡️Attend the “Best of the Journal of the American Medical Association and the New England Journal of Medicine” session moderated by @JAMA_current Associate Editor Wolfgang Winkelmayer 🗓️Today, Nov 7, at 2:00 PM. 📍Grand Ballroom A. ja.ma/47fmsy4

JAMA_current's tweet image. At #KidneyWk? 

➡️Attend the “Best of the Journal of the American Medical Association and the New England Journal of Medicine” session moderated by @JAMA_current Associate Editor Wolfgang Winkelmayer

🗓️Today, Nov 7, at 2:00 PM.
📍Grand Ballroom A. 

ja.ma/47fmsy4

#VExUS in special circumstances. Shoutout to the study by @ArgaizR and team in patients with severe TR #KidneyWk

NephroP's tweet image. #VExUS in special circumstances.
Shoutout to the study by @ArgaizR and team in patients with severe TR
#KidneyWk

Finally getting to sit and listen to Dr. Beaubien’s #VExUS talk. I’m usually tied up with other workshop tasks when he or Eduardo Argaiz are presenting - feels good to share the stage today and actually enjoy the learning in peace. #KidneyWk

NephroP's tweet image. Finally getting to sit and listen to Dr. Beaubien’s #VExUS talk. I’m usually tied up with other workshop tasks when he or Eduardo Argaiz  are presenting - feels good to share the stage today and actually enjoy the learning in peace. #KidneyWk


In hospitalized hypoalbuminemic patients who need HD, albumin administration before the dialysis results in fewer episodes of hypotension and improves fluid removal. #KidneyWk pmc.ncbi.nlm.nih.gov/articles/PMC77…

arvindcanchi's tweet image. In hospitalized hypoalbuminemic patients who need HD, albumin administration before the dialysis results in fewer episodes of hypotension and improves fluid removal. #KidneyWk 
pmc.ncbi.nlm.nih.gov/articles/PMC77…
arvindcanchi's tweet image. In hospitalized hypoalbuminemic patients who need HD, albumin administration before the dialysis results in fewer episodes of hypotension and improves fluid removal. #KidneyWk 
pmc.ncbi.nlm.nih.gov/articles/PMC77…

#kidneywk 2025 off to a fabulous start with a moving opening address from our president ⁦@proychaudhuryMD⁩ 🙏🏽for highlighting ⁦@UTSWNephrology⁩ ⁦@Vishal_D_Patel⁩ lab’s discoveries that hold promise for an ADPKD cure!

samirparikhmd's tweet image. #kidneywk 2025 off to a fabulous start with a moving opening address from our president ⁦@proychaudhuryMD⁩ 

🙏🏽for highlighting ⁦@UTSWNephrology⁩ ⁦@Vishal_D_Patel⁩ lab’s discoveries that hold promise for an ADPKD cure!
samirparikhmd's tweet image. #kidneywk 2025 off to a fabulous start with a moving opening address from our president ⁦@proychaudhuryMD⁩ 

🙏🏽for highlighting ⁦@UTSWNephrology⁩ ⁦@Vishal_D_Patel⁩ lab’s discoveries that hold promise for an ADPKD cure!

👏 So proud to see our Mayo Clinic Nephrology fellows deliver outstanding oral and poster presentations at American Society of Nephrology #KidneyWk 2025 — showcasing excellence, innovation, and collaboration. 🙏🏻 Thanks 😊 @ASNKidney @Arjun_Mohan1 @h4amer @k1dneyMD @wisit661

MayoClinicNeph's tweet image. 👏  So proud to see our Mayo Clinic Nephrology fellows deliver outstanding oral and poster presentations at American Society of Nephrology #KidneyWk 2025 — showcasing excellence, innovation, and collaboration.
🙏🏻 Thanks 😊 @ASNKidney 
@Arjun_Mohan1 @h4amer @k1dneyMD @wisit661
MayoClinicNeph's tweet image. 👏  So proud to see our Mayo Clinic Nephrology fellows deliver outstanding oral and poster presentations at American Society of Nephrology #KidneyWk 2025 — showcasing excellence, innovation, and collaboration.
🙏🏻 Thanks 😊 @ASNKidney 
@Arjun_Mohan1 @h4amer @k1dneyMD @wisit661

✅ Presented today at #KidneyWk: Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial, from @JAMA_current 🔗 Free to read online. ja.ma/47Tmc79

JAMA_current's tweet image. ✅ Presented today at #KidneyWk: Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial, from @JAMA_current

🔗 Free to read online. ja.ma/47Tmc79

Your Legacy at #KidneyWk and around the world 🇵🇭🇺🇸

edgarvlermamd's tweet image. Your Legacy at #KidneyWk and around the world 
🇵🇭🇺🇸
edgarvlermamd's tweet image. Your Legacy at #KidneyWk and around the world 
🇵🇭🇺🇸

Loading...

Something went wrong.


Something went wrong.